NET
Beyond's analysis on NET
- — Perspective Therapeutics advances its radiopharmaceutical pipeline with accepted neuroendocrine tumor data for major symposium presentation
- — First‑half 2026 results show margin expansion and strong net cash flow, confirming the Ignite roadmap and full‑year guidance
- — Company reports H1 2026 margin expansion and strong net cash flow while advancing its Ignite strategic plan and confirming full-year guidance
- — Recordati posts solid H1 2026 growth with revenue up 6.6% and EBITDA up 8.8%
Recent news mentioning NET
- — Edgescan Atomic Enables On-Demand Autonomous Penetration Testing
- — Pacira BioSciences and Caregiver Action Network Announce New Survey on Gaps in Preparing Families for Postsurgical Recovery at Home
- — Elsevier and JAMA Network sign strategic content agreement for ClinicalKey AI
- — Banca Generali, a settembre la raccolta netta supera il mezzo miliardo
- — Binetti: "Tre paure da affrontare nel cancro alla prostata, ma il paziente non è la sua malattia"
- — Kabinett: Kranken- und Rentenbeiträge steigen für Gutverdiener
- — Deutsche Bahn: Drei Tage Büropflicht: Bahn-Beschäftigte gehen ihren Vorstand im Intranet an
- — JONES SODA ANNOUNCES PRELIMINARY THIRD QUARTER NET REVENUE OF $13.3 MILLION, UP APPROXIMATELY 196% YEAR-OVER-YEAR
- — Perspective Therapeutics Announces Acceptance of [212Pb]VMT-α-NET Data for Presentation at the NANETS 2026 Multidisciplinary NET Medical Symposium
- — Wer hat Schutzmaßnahmen?: Firmen zumeist nicht speziell für KI-Angriffe gewappnet
- — Kabinett: Kabinett beschließt Strafen für sexualisierte Deepfakes
- — Exportprognose: Verband rechnet mit stärker steigenden Ausfuhren